Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated

Two Phase 2 clinical trials called ‘Elektra’ and ‘Arcade’ have been initiated. They will investigate the drug OV935/TAK-935 as a potential treatment for paediatric patients with rare epilepsies. For more…

Continue Reading Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated
New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
blickpixel / Pixabay

New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy

Researchers at the University of Utah are working on developing computational tools that can be used to help identify the genetic changes underlying early infantile epileptic encephalopathy. For more detailed…

Continue Reading New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy

Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease

Avrobio has received no objection from Health Canada for their clinical trial application for their Phase 1/2 study of an investigational gene therapy for Gaucher disease. Following this news, Avrobio…

Continue Reading Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease
Close Menu